Is Clearside Biomedical Stock a Good Investment?
Clearside Biomedical Investment Advice | CLSD |
- Examine Clearside Biomedical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Clearside Biomedical's leadership team and their track record. Good management can help Clearside Biomedical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact Clearside Biomedical's business and its evolving consumer preferences.
- Compare Clearside Biomedical's performance and market position to its competitors. Analyze how Clearside Biomedical is positioned in terms of product offerings, innovation, and market share.
- Check if Clearside Biomedical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Clearside Biomedical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Clearside Biomedical stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Clearside Biomedical is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Clearside Biomedical Stock
Researching Clearside Biomedical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 13.0% of the company shares are held by company insiders. The company has Price/Earnings (P/E) ratio of 130.0. Clearside Biomedical recorded a loss per share of 0.28. The entity had not issued any dividends in recent years.
To determine if Clearside Biomedical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Clearside Biomedical's research are outlined below:
| Clearside Biomedical generated a negative expected return over the last 90 days | |
| Clearside Biomedical has high historical volatility and very poor performance | |
| Clearside Biomedical has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 1.66 M. Net Loss for the year was (34.35 M) with profit before overhead, payroll, taxes, and interest of 3.37 M. | |
| Clearside Biomedical currently holds about 29.03 M in cash with (24.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 13.0% of the company shares are held by company insiders |
Clearside Biomedical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Clearside Biomedical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Clearside Biomedical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Clearside Biomedical's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 31.78 M.Basic technical analysis of Clearside Stock
As of the 21st of July, Clearside Biomedical shows the mean deviation of 3.19, and Risk Adjusted Performance of (0.12). Clearside Biomedical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Clearside Biomedical market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if Clearside Biomedical is priced correctly, providing market reflects its regular price of 0.41 per share. As Clearside Biomedical is a penny stock we also strongly suggest to validate its jensen alpha numbers.Clearside Biomedical's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Clearside Biomedical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Clearside Biomedical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Clearside Biomedical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Clearside Biomedical's Outstanding Corporate Bonds
Clearside Biomedical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Clearside Biomedical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Clearside bonds can be classified according to their maturity, which is the date when Clearside Biomedical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Understand Clearside Biomedical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Clearside Biomedical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | (0.72) | |||
| Mean Deviation | 3.19 | |||
| Coefficient Of Variation | (718.01) | |||
| Standard Deviation | 6.03 | |||
| Variance | 36.42 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (1.00) | |||
| Total Risk Alpha | (1.70) | |||
| Treynor Ratio | (0.73) | |||
| Maximum Drawdown | 38.25 | |||
| Value At Risk | (5.56) | |||
| Potential Upside | 6.02 | |||
| Skewness | (3.71) | |||
| Kurtosis | 17.07 |
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | (0.72) | |||
| Mean Deviation | 3.19 | |||
| Coefficient Of Variation | (718.01) | |||
| Standard Deviation | 6.03 | |||
| Variance | 36.42 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (1.00) | |||
| Total Risk Alpha | (1.70) | |||
| Treynor Ratio | (0.73) | |||
| Maximum Drawdown | 38.25 | |||
| Value At Risk | (5.56) | |||
| Potential Upside | 6.02 | |||
| Skewness | (3.71) | |||
| Kurtosis | 17.07 |
Consider Clearside Biomedical's intraday indicators
Clearside Biomedical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Clearside Biomedical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Clearside Biomedical time-series forecasting models is one of many Clearside Biomedical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Clearside Biomedical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Clearside Stock media impact
There is far too much social signal, news, headlines, and media speculation about Clearside Biomedical that are available to investors today. This information is accessible both publicly - through Clearside Biomedical's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Clearside-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Clearside Biomedical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Clearside Biomedical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Clearside Biomedical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Clearside Biomedical alpha.
Clearside Biomedical Corporate Management
| MD MBA | Chief AdvisorRetina | Profile | |
| Jenny Kobin | Head Relations | Profile | |
| FRCOphth FRCS | Chief Officer | Profile | |
| Leslie Zacks | Chief Compliance Officer, General Counsel | Profile | |
| Charles Deignan | Chief Officer | Profile | |
| Susan Coultas | Chief Officer | Profile | |
| Leslie JD | Secretary | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearside Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For information on how to trade Clearside Stock refer to our How to Trade Clearside Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearside Biomedical. If investors know Clearside will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearside Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Clearside Biomedical is measured differently than its book value, which is the value of Clearside that is recorded on the company's balance sheet. Investors also form their own opinion of Clearside Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Clearside Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearside Biomedical's market value can be influenced by many factors that don't directly affect Clearside Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Clearside Biomedical's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Clearside Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearside Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.